Cerebral Small Vessel Disease Burden: An Independent Biomarker for Anomia Treatment Responsiveness in Chronic Stroke Patients With Aphasia.
Maria Varkanitsa, Claudia Peñaloza, Andreas Charidimou and 1 others
PMID 37290492WHAT IT FOUND
Stroke patients with more small vessel disease in the brain showed less improvement in naming after semantic therapy.
This held true even after accounting for aphasia severity and lesion size. Scanning for these markers may help predict who will benefit most from treatment.
Key findings
01Patients with moderate-to-severe deep white matter hyperintensities or generalized cerebral atrophy exhibited lower improvement in naming accuracy after treatment compared to those with mild or no changes.
02A combined score of small vessel disease burden was significantly associated with poorer response to anomia treatment, independent of baseline aphasia severity and stroke lesion volume.
03Small vessel disease severity was linked to lower non-verbal executive function at baseline but showed no association with baseline language abilities.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was retrospective and had a small sample size of 30 patients. The time since stroke varied widely among participants, although statistical models adjusted for this factor. The findings are hypothesis-generating and require validation in larger samples before clinical application.
The easy way to misread this
Do not assume this study proves that treating small vessel disease improves language recovery. It only identifies a structural marker associated with poorer response to existing therapy. The research is hypothesis-generating and based on a small sample, so it does not yet support changing standard clinical protocols.